All News

Clinical trial data that leads to FDA approvals may be difficult for the general public to understand.

Pembrolizumab (Keytruda) combination therapy may improve outcomes for patients with metastatic non-small cell lung cancer.

The presence of certain bacteria may enhance response to PD-1 inhibitors in melanoma.

Once-weekly pill has the potential to prevent 20% of new HIV infections.

Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.

Mitochondrial inhibitors may be a beneficial add-on therapy for glioblastoma containing gene fusion.

New research indicates there are distinct subgroups of osteoarthritis that can impact treatment.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Americans to walk, bike or run 7,000 miles during February bringing awareness to 7,000 rare diseases affecting 30 million Americans.

Researchers are developing novel treatments to support weight management, although limited data supports their use in diabetes.

A number of landmark clinical studies in the field of MS have been published, shaping how the disease is treated.

Insurers place more prior authorization requirements on PCSK9 inhibitors than other similar cholesterol treatments.

More than 60% of very elderly patients with stage 3 lung cancer did not receive treatment.

Consistent delivery of an electric field could drastically increase glioblastoma survival.

States are now allowed to require able-bodied, working-age Medicaid beneficiaries to be employed or participate in community engagement activities.

Tisagenlecleucel (Kymriah) under review to treat non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia.

An HIV protein may interact with brain cells to increase neurodegeneration.

Top news of the day from across the health care landscape.

Study finds that ADHD treatment recommendations are not always followed.

Top news of the day from across the health care landscape.

To better enhance transparency around FDA drug approval decisions, the agency is launching a pilot program aimed at improving provider access to key information related to new drugs.

Weight can be a difficult topic for patients, as people with diabetes often have trouble losing weight and medications can cause weight gain.

CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.

Patients with a high risk of recurrent breast cancer may not receive chemotherapy.

Sandoz proposed adalimumab biosimilar demonstrates similarity to reference product in safety, efficacy, and quality measures.

Novel HIV treatment protected immune cells against HIV for nearly a month.

More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.

The gasdermin B gene may increase cell death and inflammation in the airways associated with asthma.

FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.